A Selective Cellular Screening Assay for B-Raf and c-Raf Kinases
Tsuyoshi Ishii(Takeda (Japan)), Nobuhiro Noro(GlaxoSmithKline (United Kingdom))
Cited by 3
Related Papers
CETSA quantitatively verifies in vivo target engagement of novel RIPK1 inhibitors in various biospecimens
|Scientific Reports|2017|49